Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 569.45
-9.25 (-1.60%)
At close: Feb 12, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 136.16 billion as of February 13, 2026. Its market cap has decreased by -3.53% in one year.
Market Cap
136.16B
Enterprise Value
148.04B
Revenue
50.92B
Ranking
n/a
PE Ratio
24.95
Stock Price
569.45
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 136.16B, an increase of 83,077.36%. That is a compound annual growth rate of 33.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 138.19B | -4.86% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 457.53B |
| J. B. Chemicals & Pharmaceuticals | 305.76B |
| AstraZeneca Pharma India | 220.67B |
| Jubilant Pharmova | 148.72B |
| Caplin Point Laboratories | 132.23B |
| Rubicon Research | 128.62B |
| CORONA Remedies | 98.72B |
| Viyash Scientific | 97.40B |